Erschienen in:
03.06.2020 | Less is more in Intensive Care
Biomarkers in the ICU: less is more? Not sure
verfasst von:
Pedro Póvoa, Jorge I. F. Salluh, Thiago Lisboa
Erschienen in:
Intensive Care Medicine
|
Ausgabe 1/2021
Einloggen, um Zugang zu erhalten
Excerpt
In the twenty-first century, there is still no gold-standard test to diagnose infection [
1] and it relies on a combination of unspecific systemic signs, signs of organ involvement, and microbiologic documentation [
2]. Since these clinical signs lack accuracy and microbiologic results are unavailable early in clinical course, antibiotics are frequently prescribed without a definite diagnosis of infection [
3]. These limitations led clinicians to search for biomarkers that could be used as surrogate markers of infection [
4,
5]. From the hundreds of biomarkers that were studied, only two, C-reactive protein (CRP) and procalcitonin (PCT), are present in our daily practice. Despite frequent, routine use is not backed by undisputable evidence. …